Sign in
4

Changes in Ownership

Cytosorbents Corp Filed Acc 0001144204-18-015453

Chief Financial Officer sold 11,176 shares at $8.25 ($92,202)

  • Chief Financial Officer acquired 11,176 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
BLOCH KATHLEEN P. Chief Financial Officer 2018-03-15 Option exercise +11,176 $4.69 $52,415 261,246 D
BLOCH KATHLEEN P. Chief Financial Officer 2018-03-15 Sale −11,176 $8.25 $92,202 250,070 D
Derivatives
BLOCH KATHLEEN P. Chief Financial Officer 2018-03-15 Option exercise · Stock Option (Right to Buy) −11,176 24,920 D
Open-market sales · 11,176 sh · avg $8.25 · $92,202
Loading xslF345X03/tv488826_4.xml…